Steve Liberty

Experience

• 

  Canadian Armed Forces

  Jan 1985 - Jan 1991

  Engineering Officer

  Rank upon honorable discharge: Captain

• 

  Eli Lilly and Company

  Jan 1992 - Jan 1997

  Operations and Supply

  Business Development Leader, North American Manufacturing (1996 –1997) - Indianapolis, IN, USAManager, Distribution and Customer Service (1994 –1995) - Toronto, CanadaTotal Quality Advisor (1993 - 1994) - Toronto, CanadaManufacturing Associate (1992 – 1993) - Toronto, Canada

• 

  AstraZeneca

  Jan 1997 - Jan 2003

  Led all Production, QA, Engineering and Supply Chain in Australia in three plants (300,000 ft2 total) – dual reporting to Vice President of International Manufacturing and Australia Marketing Company President. Responsible for supply of both solid dose and sterile/parenteral liquids to Australia, UK, Europe, Japan, and South East Asia -- annual market revenue approx. $500 Million - annual site expenses of $60 Million

  • Director Manufacturing

    Jan 2000 - Jan 2003

  • Director Manufacturing

    Jan 1997 - Jan 2000
• 

  AstraZeneca

  Jan 2004 - Dec 2005

  Executive Director & General Manager, Manufacturing and Supply

  Led all technical and business operations at plant site – annual site expenses of $85 Million, 800 personnel, 500,000 ft2 facilities. Supply of sterile/parenteral liquids for USA, Europe, and Canada -- annual market revenue approx. $1 Billion. Reported to US Vice President Supply and Manufacturing.

• 

  Patheon

  Jan 2005 - Jan 2009

  Sr. Vice President Operations

  All commercial operations (“Profit & Loss”) at four contract pharmaceutical manufacturing sites and one central QC laboratory in Canada and USA – annual Revenue approx. $300 Million, EBITDA of approx. $100 Million, 1,700 personnel, approx. 1,100,000 ft2 at five facilities. Reported to President, North America. Member of global Executive Committee.Provided executive-level support to global business development and contract negotiation process.

• 

  Teva Pharmaceuticals

  Jan 2009 - Jan 2013

  Vice President Operations & Supply

  Led all technical and product supply operations across four production sites within Teva Canada – annual site expenses of $140+ Million, 1,400+ personnel, 900,000 ft2 facilities.Supply of generic conventional and high potent solid oral-dosage forms and penicillins (solids and suspensions) for USA, Canada, and Europe -- annual market revenue approx. $2 Billion. Dual reporting to Canadian CEO and to EVP Americas Tech Ops. Member of Canada Executive Committee and Americas Tech Ops Leadership Team. Show less

• 

  Apotex Inc.

  Jan 2013 - Jan 2023

  Leadership of all Apotex global API and Finished Dosage Manufacturing, Supply Chain and Procurement (including Direct and Indirect and products supplied by 3rd party partners), Engineering, Tech Ops, and EHS. Report directly to CEO. Member of Apotex Global Executive Management Committee. 4,700 employees at 10 production sites in Canada (4), USA (1), Mexico (2), India (2), Netherlands. (> 4 Million ft2 TOTAL). >15 Billion Dosages annually. Provided technical and strategic manufacturing leadership to pharmaceutical manufacturing operations at Apotex Inc in Toronto and Richmond Hill.Responsible for product supply, new product launch, and quality remediation at Richmond Hill liquids operations - Warning Letter remediation leading to subsequent Zero-483 FDA audit.

  • Executive Vice President - Global Supply & Manufacturing

    Jan 2015 - Jan 2023

  • Vice President Manufacturing & Product Supply

    Jan 2013 - Jan 2015
• 

  Self Employed

  Oct 2023 - now

  Board / Advisory / Consulting / Interim Executive Management